<code id='5691C55E95'></code><style id='5691C55E95'></style>
    • <acronym id='5691C55E95'></acronym>
      <center id='5691C55E95'><center id='5691C55E95'><tfoot id='5691C55E95'></tfoot></center><abbr id='5691C55E95'><dir id='5691C55E95'><tfoot id='5691C55E95'></tfoot><noframes id='5691C55E95'>

    • <optgroup id='5691C55E95'><strike id='5691C55E95'><sup id='5691C55E95'></sup></strike><code id='5691C55E95'></code></optgroup>
        1. <b id='5691C55E95'><label id='5691C55E95'><select id='5691C55E95'><dt id='5691C55E95'><span id='5691C55E95'></span></dt></select></label></b><u id='5691C55E95'></u>
          <i id='5691C55E95'><strike id='5691C55E95'><tt id='5691C55E95'><pre id='5691C55E95'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:86799
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          NEJM study measures Covid brain fog, impact on IQ
          NEJM study measures Covid brain fog, impact on IQ

          AdobeOfallthelingeringsymptomsoflongCovid,difficultyfocusingandthinking,knownasbrainfog,maybethemost

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

          SangTan/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewslette